JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on December 13, 2005; DOI: 10.1124/jpet.105.095828


0022-3565/06/3171-428-438$20.00
JPET 317:428-438, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.095828v1
317/1/428    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'Sullivan, S. E.
Right arrow Articles by Randall, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'Sullivan, S. E.
Right arrow Articles by Randall, M. D.

CARDIOVASCULAR

Further Characterization of the Time-Dependent Vascular Effects of {Delta}9-Tetrahydrocannabinol

Saoirse E. O'Sullivan, David A. Kendall, and Michael D. Randall

School of Biomedical Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom

We have previously shown that over time (2 h), the active ingredient of cannabis, {Delta}9-tetrahydrocannabinol (THC), produces peroxisome proliferator-activated receptor (PPAR) {gamma}-mediated vasorelaxation of conduit arteries. We have now investigated whether incubation with THC affects agonist-stimulated contractile (methoxamine) and endothelium-dependent vasorelaxant (acetylcholine) responses in the rat superior mesenteric artery (G0) and aorta by myography. We have also investigated whether similar responses are observed in isolated resistance (G3) vessels of the mesenteric bed. In both the aorta and G0, incubation with 10 µM THC for 2 h, but not 10 min, significantly attenuated the contractile responses to methoxamine. This effect of THC was abolished in the presence of the enzyme catalase, which breaks down H2O2, and was reduced in the presence of the superoxide dismutase inhibitor diethyldithiocarbamate (DETCA), but it was not PPAR{gamma}-mediated. THC also inhibited calcium influx in a H2O2-dependent manner. In G0, but not the aorta, incubation with 10 µM THC for 2 h significantly enhanced endothelium-dependent vasorelaxation. This was inhibited by a PPAR{gamma} antagonist, 2-chloro-5-nitro-N-phenylbenzamide (GW9662), catalase, and DETCA, but not by the NO synthase inhibitor NG-nitro-L-arginine methyl ester. By contrast, in G3, no time-dependent vasorelaxation of precontracted arteries to THC was observed, and incubation with THC led to potentiation of contractile responses and blunting of vasorelaxation to acetylcholine, which seems to involve inhibition of endothelium-derived hyperpolarizing factor (EDHF) production, and agonist-stimulated production of EDHF. These data demonstrate further the time-dependent vascular actions of THC and also highlight the heterogenous effects of THC in different arterial types.


Received September 19, 2005; accepted December 9, 2005.

Address correspondence to: Dr. Saoirse E. O'Sullivan, School of Biomedical Sciences, E Floor, Queen's Medical Centre, University of Nottingham, NG7 2UH, UK. E-mail: saoirse.o'sullivan{at}nottingham.ac.uk




This article has been cited by other articles:


Home page
J EndocrinolHome page
I. C Villar, A. J Hobbs, and A. Ahluwalia
Sex differences in vascular function: implication of endothelium-derived hyperpolarizing factor
J. Endocrinol., June 1, 2008; 197(3): 447 - 462.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. E. O'Sullivan, M. D. Randall, and S. M. Gardiner
The in Vitro and in Vivo Cardiovascular Effects of {Delta}9-Tetrahydrocannabinol in Rats Made Hypertensive by Chronic Inhibition of Nitric-Oxide Synthase
J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 663 - 672.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.